drugs like glp 1 Weight loss don't work for everyone—here's why How to Find a Health
Description
The effect of a subcutaneous infusion of GLP-1, OXM, and PYY on energy intake and expenditure in obese volunteers
1 October 2015
Participants lost an average of 16.6% of their body weight, a significant improvement compared to just 3.2% in the placebo group
N Engl J Med 2023;389:222132
doi: 10.1172/JCI112013
Due to a growing demand for new treatment options for type 2 diabetes (T2DM), several classes of novel antidiabetic medications have been developed
